Word: drug
(lookup in dictionary)
(lookup stats)
Dates: during 2010-2019
Sort By: most recent first
(reverse)
...does the abuse of performance enhancers extend beyond professional sports? It might surprise some to know that in the realm of academics, there is a growing trend, both in high school and in college, of students abusing prescription drugs to boost their ability to study and concentrate on tests. Use of any type of prescription drug for cognitive gain should be looked down upon with the same amount of social repugnance as juicing up for a sport...
...addition, the Brandeis policy states that evidence of drug and/or alcohol consumption “may raise a presumption of physical and/or mental incapacity,” further broadening the definition of sexual assault...
First, the current treatment regimen requires patients take a cocktail of four drugs, all nearly half a century old, for at least six months. The logistical and financial hurdles associated with paying for and completing treatment, however, virtually guarantee noncompliance and relapse. Second, in a cascade effect, noncompliance selects for drug-resistant strains of the mutated pathogen, precipitating the rise of multi-drug resistant and extremely drug-resistant tuberculosis. Treatment for drug-resistant TB with second-line drugs is astronomically more expensive, more time-intensive, and associated with more toxic side effects. Third, the rise of TB and human immunodeficiency...
Moving forward, progress in developing new drugs has long been stalled by a combination of inadequate funding, regulatory bottlenecks, and tepid support from the pharmaceutical industry. Thanks largely to years of advocacy and the establishment of innovative public-private partnerships spanning the two sectors, new drugs and new models of clinical development are finally in the pipeline. Instead of developing new drugs one-by-one, the Critical Path to TB Regimens Initiative would bring together drug developers, under a “patients-first” commitment, to test their compounds together as an entirely new four-drug combination?...
...therapeutic regimens represent, however, only half the solution. Without commensurate scale-up of community-based treatment programs—the “social” dimension of treatment—or reform of inefficient drug delivery mechanisms in developing countries, TB treatment will remain inaccessible, ineffective, and ultimately futile. To finally turn the clock back on the spread of TB and its even more dangerous resistant strains, we need a concerted effort spanning industry, state, the public sector, and citizenry...